Starling Oncology, Inc. Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities
Starling Oncology, Inc. (STLN) reported Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-03-12
- Starling Oncology, Inc. unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2025 was $0.00.
- Starling Oncology, Inc. unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2024 was $0.00.
- Starling Oncology, Inc. unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2023 was $0.00.
- Starling Oncology, Inc. unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-26 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |